Physician profile
Johnathan Lloyd Wise
NPI 1992125355
$6,751.54
in general payments reported to CMS, 2019-2025
25 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $924 · 2020: $4,331 · 2021: $168 · 2022: $405 · 2023: $360 · 2024: $289 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $923.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $923.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,874.57 | 2019-2020 | |
| Abbvie INC. | $356.72 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Pfizer INC. | $325.53 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $205.22 | 2023-2025 | Gemtesa, Myfembree |
| Amgen INC. | $182.54 | 2019-2025 | Evenity, Prolia, Prolia |
| Kowa Pharmaceuticals America, INC. | $109.22 | 2020-2021 | |
| Antares Pharma, INC. | $81.86 | 2019-2020 | |
| Millicent US INC | $81.24 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Organon LLC | $68.71 | 2022-2025 | Jada System |
| Hologic Sales and Service, LLC | $58.30 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $57.69 | 2022-2024 | |
| Astellas Pharma US INC | $51.61 | 2024-2025 | Veozah |
| Smith+Nephew, INC. | $47.84 | 2022-2023 | Stravix Pl |
| Davol INC. | $29.18 | 2023 | Arista Ah Flexitip |
| Exeltis, USA INC. | $28.87 | 2025 | Slynd |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $28.35 | 2025 | |
| Baxter Healthcare | $26.28 | 2019 | |
| Kyowa Kirin, INC. | $22.17 | 2023 | Crysvita |
| Merck Sharp & Dohme LLC | $21.25 | 2025 | Gardasil 9 |
| Mylan Pharmaceuticals INC. | $19.77 | 2022 | |
| Avion Pharmaceuticals | $19.19 | 2023 | Balcoltra |
| Bayer Healthcare Pharmaceuticals INC. | $18.97 | 2025 | |
| Lilly USA, LLC | $16.95 | 2024 | Zepbound |
| Therapeuticsmd, INC. | $15.46 | 2022 | |
| Evofem Biosciences, INC. | $4.05 | 2025 | Solosec, Phexx, Phexxi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnathan Wise listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.